ScholarLens Back to search
2008•EpilepsiaRequires access

The komet study: an open-label, randomized, parallel-group trial comparing the efficacy and safety of levetiracetam with sodium valproate and carbamazepine as monotherapy in subjects with newly diagnosed epilepsy

Eugen Trinka, Wim Van Paesschen, Yngve Hallström, Petr Hon, Anthony Guy Marson, Giovanni Muscas, Reetta K. Kälviäinen, S. Buyle, Jacqueline Marovac, Pascal Edrich, Bernd Pohlmann‐Eden

Open publisher page 7 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Levetiracetam, Carbamazepine, Open label, Randomized controlled trial, Epilepsy, Medicine, Anticonvulsant, Anesthesia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The komet study: an open-label, randomized, parallel-group trial comparing the efficacy and safety of levetiracetam with sodium valproate and carbamazepine as monotherapy in subjects with newly diagnosed epilepsy — Research Paper | ScholarLens